Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Timothy Grein"'
Autor:
Berlise Yengwa Bakam, Romeo Urich Fosso, Timothy Grein, Derek Tantoh Ndinteh, Sebastian Maxeiner, Stéphane Zingue, Roman A Blaheta, Dieudonne Njamen
Publikováno v:
Journal of Functional Foods, Vol 114, Iss , Pp 106088- (2024)
Pumpkin seeds are claimed to treat prostate tumour/cancer. The in vitro (ability to inhibit cell growth through MTT assay) and in vivo (ability to prevent testosterone-induced BPH in rats at the doses of 125, 250, 500 and 1000 mg/kg BW) of six edible
Externí odkaz:
https://doaj.org/article/ef768c7df15b4f42bb8cc1b9b25e80c6
Autor:
Igor Tsaur, Anita Thomas, Eva Juengel, Sebastian Maxeiner, Timothy Grein, Quynh Chi Le, Veronika Muschta, Jochen Rutz, Felix K. H. Chun, Roman A. Blaheta
Publikováno v:
Biology, Vol 10, Iss 10, p 1007 (2021)
The serum level of soluble (s)E-cadherin is elevated in several malignancies, including prostate cancer (PCa). This study was designed to investigate the effects of sE-cadherin on the behavior of PCa cells in vitro, with the aim of identifying a pote
Externí odkaz:
https://doaj.org/article/4096ec2ba66a4e37835f6aa48dba26ac
Autor:
Hui Xie, Jochen Rutz, Sebastian Maxeiner, Timothy Grein, Anita Thomas, Eva Juengel, Felix K.-H. Chun, Jindrich Cinatl, Axel Haferkamp, Igor Tsaur, Roman A. Blaheta
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4682
Combined cisplatin–gemcitabine (GC) application is standard for treating muscle-invasive bladder cancer. However, since rapid resistance to treatment often develops, many patients turn to supplements in the form of plant-based compounds. Sulforapha
Autor:
Jochen Rutz, Sebastian Maxeiner, Timothy Grein, Marlon Sonnenburg, Salma El Khadir, Nino Makhatelashvili, Johanna Mann, Hui Xie, Jindrich Cinatl, Anita Thomas, Felix K.-H. Chun, Axel Haferkamp, Roman A. Blaheta, Igor Tsaur
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 19; Pages: 10996
Combined cisplatin–gemcitabine treatment causes rapid resistance development in patients with advanced urothelial carcinoma. The present study investigated the potential of the natural isothiocyanates (ITCs) allyl-isothiocyanate (AITC), butyl-isoth
Autor:
Blaheta, Carolin Siech, Jochen Rutz, Sebastian Maxeiner, Timothy Grein, Marlon Sonnenburg, Igor Tsaur, Felix K.-H. Chun, Roman A.
Publikováno v:
Cancers; Volume 14; Issue 2; Pages: 363
Insulin-like growth factor-1 (IGF-1)-related signaling is associated with prostate cancer progression. Links were explored between IGF-1 and expression of integrin adhesion receptors to evaluate relevance for growth and migration. Androgen-resistant
Autor:
Carolin Siech, Jochen Rutz, Sebastian Maxeiner, Timothy Grein, Marlon Sonnenburg, Igor Tsaur, Felix K.-H. Chun, Roman A. Blaheta
Publikováno v:
Cancers, Vol 14, Iss 363, p 363 (2022)
Cancers
Cancers
Simple Summary Insulin-like growth factor-1 (IGF-1) is a growth hormone and is implicated in prostate cancer progression. Most prostate cancers begin in an androgen-dependent state so that androgen deprivation therapy results in improved clinical out
Autor:
Quynh Chi Le, Veronika Muschta, Felix K.-H. Chun, Anita Thomas, Roman A. Blaheta, Eva Juengel, Jochen Rutz, Sebastian Maxeiner, Igor Tsaur, Timothy Grein
Publikováno v:
Biology
Volume 10
Issue 10
Biology, Vol 10, Iss 1007, p 1007 (2021)
Volume 10
Issue 10
Biology, Vol 10, Iss 1007, p 1007 (2021)
Simple Summary Despite recent advances in the therapeutic management of metastasized prostate cancer, disease progression is still inevitable, with often fatal outcomes. Elucidating molecular mechanisms crucial to cancer development and progression i
Autor:
Igor Tsaur, Anita Thomas, Michelle Monecke, Marion Zugelder, Jochen Rutz, Timothy Grein, Sebastian Maxeiner, Hui Xie, Felix K.-H. Chun, Florian Rothweiler, Jindrich Cinatl, Martin Michaelis, Axel Haferkamp, Roman A. Blaheta
Publikováno v:
Cancers
Cancers; Volume 14; Issue 13; Pages: 3111
Cancers; Volume 14; Issue 13; Pages: 3111
Despite recent advances in the treatment of metastatic prostate cancer (PCa), resistance development after taxane treatments is inevitable, necessitating effective options to combat drug resistance. Previous studies indicated antitumoral properties o
Autor:
Man Chun John Ma, Saber Tadros, Alyssa Bouska, Tayla Heavican, Haopeng Yang, Qing Deng, Dalia Moore, Ariz Akhter, Keenan Hartert, Neeraj Jain, Jordan Showell, Sreejoyee Ghosh, Lesley Street, Marta Davidson, Christopher Carey, Joshua Tobin, Deepak Perumal, Julie M. Vose, Matthew A. Lunning, Aliyah R. Sohani, Benjamin J. Chen, Shannon Buckley, Loretta J. Nastoupil, R. Eric Davis, Jason R. Westin, Nathan H. Fowler, Samir Parekh, Maher Gandhi, Sattva Neelapu, Douglas Stewart, Kapil Bhalla, Javeed Iqbal, Timothy Greiner, Scott J. Rodig, Adnan Mansoor, Michael R. Green
Publikováno v:
Haematologica, Vol 107, Iss 3 (2021)
B-cell non-Hodgkin lymphoma (B-NHL) encompasses multiple clinically and phenotypically distinct subtypes of malignancy with unique molecular etiologies. Common subtypes of B-NHL, such as diffuse large B-cell lymphoma, have been comprehensively interr
Externí odkaz:
https://doaj.org/article/fc029b784cbf42fa99be555459101032